70 related articles for article (PubMed ID: 16835828)
1. Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta's in epithelial ovarian tumors.
Inan S; Vatansever S; Celik-Ozenci C; Sanci M; Dicle N; Demir R
Histol Histopathol; 2006 Oct; 21(10):1055-64. PubMed ID: 16835828
[TBL] [Abstract][Full Text] [Related]
2. The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II.
Skirnisdottir I; Seidal T; Åkerud H
Int J Oncol; 2016 Mar; 48(3):998-1006. PubMed ID: 26783205
[TBL] [Abstract][Full Text] [Related]
3. TGF beta1 expression and angiogenesis in colorectal cancer tissue.
Xiong B; Gong LL; Zhang F; Hu MB; Yuan HY
World J Gastroenterol; 2002 Jun; 8(3):496-8. PubMed ID: 12046078
[TBL] [Abstract][Full Text] [Related]
4. Role of nerve growth factor and its TRKA receptor in normal ovarian and epithelial ovarian cancer angiogenesis.
Vera C; Tapia V; Vega M; Romero C
J Ovarian Res; 2014 Aug; 7():82. PubMed ID: 25296882
[TBL] [Abstract][Full Text] [Related]
5. Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer.
Hirashima Y; Yamada Y; Matsubara J; Takahari D; Okita N; Takashima A; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
Cancer Sci; 2009 Feb; 100(2):310-5. PubMed ID: 19068081
[TBL] [Abstract][Full Text] [Related]
6. Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.
Masoumi Moghaddam S; Amini A; Morris DL; Pourgholami MH
Cancer Metastasis Rev; 2012 Jun; 31(1-2):143-62. PubMed ID: 22101807
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis Redux: An Overall Protective Role of VEGF/KDR Signaling in the Microvasculature in Pulmonary Arterial Hypertension.
Zhong Y; Yu PB
Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):1784-1787. PubMed ID: 37675636
[No Abstract] [Full Text] [Related]
8. Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.
Yoshinaga K; Ito K; Moriya T; Nagase S; Takano T; Niikura H; Yaegashi N; Sato Y
Cancer Sci; 2008 May; 99(5):914-9. PubMed ID: 18325046
[TBL] [Abstract][Full Text] [Related]
9. Lactate acidosis and simultaneous recruitment of TGF-β leads to alter plasticity of hypoxic cancer cells in tumor microenvironment.
Rastogi S; Mishra SS; Arora MK; Kaithwas G; Banerjee S; Ravichandiran V; Roy S; Singh L
Pharmacol Ther; 2023 Oct; 250():108519. PubMed ID: 37625521
[TBL] [Abstract][Full Text] [Related]
10. Expression of endocan and vascular endothelial growth factor and their correlation with histopathological prognostic parameters in pheochromocytoma.
Kocabaş M; Can M; Karaköse M; Esen HH; Kulaksizoğlu M; Karakurt F
Endocrine; 2023 Dec; 82(3):638-645. PubMed ID: 37596456
[TBL] [Abstract][Full Text] [Related]
11. The Role of TGF-
Yang Y; Ye WL; Zhang RN; He XS; Wang JR; Liu YX; Wang Y; Yang XM; Zhang YJ; Gan WJ
Evid Based Complement Alternat Med; 2021; 2021():6675208. PubMed ID: 34335834
[TBL] [Abstract][Full Text] [Related]
12. Endothelial-Tumor Cell Interaction in Brain and CNS Malignancies.
Peleli M; Moustakas A; Papapetropoulos A
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036204
[TBL] [Abstract][Full Text] [Related]
13. Tgf-Beta superfamily receptors-targets for antiangiogenic therapy?
Otten J; Bokemeyer C; Fiedler W
J Oncol; 2010; 2010():317068. PubMed ID: 20490264
[TBL] [Abstract][Full Text] [Related]
14. Utility of vascular endothelial growth factor inhibitors in the treatment of ovarian cancer: from concept to application.
Amini A; Masoumi Moghaddam S; Morris DL; Pourgholami MH
J Oncol; 2012; 2012():540791. PubMed ID: 21961001
[TBL] [Abstract][Full Text] [Related]
15. Recombinant anti-Mullerian hormone treatment attenuates primordial follicle loss after ovarian cryopreservation and transplantation.
Celik S; Ozkavukcu S; Celik-Ozenci C
J Assist Reprod Genet; 2023 May; 40(5):1117-1134. PubMed ID: 36856968
[TBL] [Abstract][Full Text] [Related]
16. FBXW7 inhibits invasion, migration and angiogenesis in ovarian cancer cells by suppressing VEGF expression through inactivation of β-catenin signaling.
Zhong L; Pan Y; Shen J
Exp Ther Med; 2021 May; 21(5):514. PubMed ID: 33791023
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer.
Göbel A; Zinna VM; Dell'Endice S; Jaschke N; Kuhlmann JD; Wimberger P; Rachner TD
BMC Cancer; 2020 Jul; 20(1):703. PubMed ID: 32727400
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of activator proteins that control follicle reserve after ovarian tissue cryopreservation/transplantation and primordial follicle loss prevention by rapamycin.
Celik S; Ozkavukcu S; Celik-Ozenci C
J Assist Reprod Genet; 2020 Sep; 37(9):2119-2136. PubMed ID: 32651677
[TBL] [Abstract][Full Text] [Related]
19. Expression of inhibitor proteins that control primordial follicle reserve decreases in cryopreserved ovaries after autotransplantation.
Celik S; Celikkan FT; Ozkavukcu S; Can A; Celik-Ozenci C
J Assist Reprod Genet; 2018 Apr; 35(4):615-626. PubMed ID: 29497951
[TBL] [Abstract][Full Text] [Related]
20. VEGF Expression to Support Targeted Therapy in Ovarian Surface Epithelial Neoplasms.
Mukherjee S; Pal M; Mukhopadhyay S; Das I; Hazra R; Ghosh S; Mondal RK; Bal R
J Clin Diagn Res; 2017 Apr; 11(4):EC43-EC46. PubMed ID: 28571149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
